Driving Innovation in ADC Development with ThioBridge® Conjugation & Linker Technology

• Assessing the role of linker architecture as a key element of ADC design
• Discussion of ThioBridge® as a Next-Generation, site-specific conjugation technology for modulation of DAR and production of homogeneous ADCs
• Supporting characterization and manufacture of bioconjugates through Abzena’s integrated offering

Speakers:

Johanna Midelet

Director Bioconjugation and Chemistry

Abzena